I think it's pretty simple if Janssen comes through with a licensing contract and significant cash component, at least a high seven figure sum + expansion of the agreement then it will rerate significantly. If it doesn't materialize and just hits a "undisclosed sum" for progress then likely just a few hundred thousand as we've seen before but wont show until the next quarterly.
Ascent Biomedical came in amongst the $5M placement in 2011.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4000 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 40248 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |